MENU
+Compare
IMCR
Stock ticker: NASDAQ
AS OF
Sep 17, 04:59 PM (EDT)
Price
$33.38
Change
-$0.43 (-1.27%)
Capitalization
1.73B

IMCR Immunocore Holdings plc Forecast, Technical & Fundamental Analysis

Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more

IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMCR with price predictions
Sep 16, 2025

IMCR in upward trend: 10-day moving average crossed above 50-day moving average on September 08, 2025

The 10-day moving average for IMCR crossed bullishly above the 50-day moving average on September 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on IMCR as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMCR just turned positive on August 21, 2025. Looking at past instances where IMCR's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMCR advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 183 cases where IMCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IMCR moved out of overbought territory on September 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where IMCR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

IMCR moved below its 50-day moving average on September 16, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMCR broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.384) is normal, around the industry mean (20.607). P/E Ratio (0.000) is within average values for comparable stocks, (53.283). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.160). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (4.757) is also within normal values, averaging (333.412).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMCR is expected to report earnings to rise 22.00% to -24 cents per share on November 05

Immunocore Holdings plc IMCR Stock Earnings Reports
Q3'25
Est.
$-0.24
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.49
Q4'24
Missed
by $0.23
Q3'24
Beat
by $0.50
The last earnings report on August 07 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 270.05K shares outstanding, the current market capitalization sits at 1.73B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTANX12.71N/A
N/A
Fidelity Asset Manager 30%
FASMX22.65N/A
N/A
Fidelity Asset Manager 50%
IHSAX20.95N/A
N/A
Hartford Small Company A
DBIWX11.14N/A
N/A
DWS Global Macro R6
EEMHX9.87N/A
N/A
MFS Emerging Markets Equity Research R6

IMCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with NRIX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
-1.79%
NRIX - IMCR
51%
Loosely correlated
-2.65%
ROIV - IMCR
47%
Loosely correlated
+1.65%
IDYA - IMCR
47%
Loosely correlated
+0.77%
KYMR - IMCR
46%
Loosely correlated
+3.17%
CGON - IMCR
45%
Loosely correlated
+3.35%
More